QuickView for platelet-derived growth factor receptor-beta signaling pathway (biogroup)

1. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)

There were no matches for platelet-derived growth factor receptor-beta signaling pathway

1. Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
2. Proteomics and Stem Cell Therapy as a New Vascularization Strategy
3. GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
4. A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer
5. Temodar and Sutent as Therapy for Melanoma